CD20 antibody–based combination therapy may reduces the adverse prognostic impact of M-protein positivity in marginal zone lymphoma

Leukemia Research Reports · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles